Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).

BACKGROUND Sudden death is a leading cause of death in patients on maintenance hemodialysis therapy. During hemodialysis sessions, the gradient between serum and dialysate levels results in rapid electrolyte shifts, which may contribute to arrhythmias and sudden death. Controversies exist about the optimal electrolyte concentration in the dialysate; specifically, it is unclear whether patient outcomes differ among those treated with a dialysate potassium concentration of 3 mEq/L compared to 2 mEq/L. STUDY DESIGN Prospective cohort study. SETTING & PARTICIPANTS 55,183 patients from 20 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) phases 1 to 5 (1996-2015). PREDICTOR Dialysate potassium concentration at study entry. OUTCOMES Cox regression was used to estimate the association between dialysate potassium concentration and both all-cause mortality and an arrhythmia composite outcome (arrhythmia-related hospitalization or sudden death), adjusting for potential confounders. RESULTS During a median follow-up of 16.5 months, 24% of patients died and 7% had an arrhythmia composite outcome. No meaningful difference in clinical outcomes was observed for patients treated with a dialysate potassium concentration of 3 versus 2 mEq/L (adjusted HRs were 0.96 [95% CI, 0.91-1.01] for mortality and 0.98 [95% CI, 0.88-1.08] for arrhythmia composite). Results were similar across predialysis serum potassium levels. As in prior studies, higher serum potassium level was associated with adverse outcomes. However, dialysate potassium concentration had only minimal impact on serum potassium level measured predialysis (+0.09 [95% CI, 0.05-0.14] mEq/L serum potassium per 1 mEq/L greater dialysate potassium concentration). LIMITATIONS Data were not available for delivered (vs prescribed) dialysate potassium concentration and postdialysis serum potassium level; possible unmeasured confounding. CONCLUSIONS In combination, these results suggest that approaches other than altering dialysate potassium concentration (eg, education on dietary potassium sources and prescription of potassium-binding medications) may merit further attention to reduce risks associated with high serum potassium levels.

[1]  D. Thornley‐Brown,et al.  Dialysate content and risk of sudden cardiac death , 2015, Current opinion in nephrology and hypertension.

[2]  A. Ortiz,et al.  Haemodialysate: long neglected, difficult to optimize, may modify hard outcomes , 2015, Clinical kidney journal.

[3]  F. Locatelli,et al.  Optimizing haemodialysate composition , 2015, Clinical kidney journal.

[4]  C. Basile,et al.  A neglected issue in dialysis practice: haemodialysate , 2015, Clinical kidney journal.

[5]  Robert A Wolfe,et al.  On a preference‐based instrumental variable approach in reducing unmeasured confounding‐by‐indication , 2015, Statistics in medicine.

[6]  R. Fluck,et al.  Potassium kinetics during hemodialysis , 2015, Hemodialysis international. International Symposium on Home Hemodialysis.

[7]  M. Jadoul,et al.  Sailing Between Scylla and Charybdis: The High Serum K–Low Dialysate K Quandary , 2014, Seminars in dialysis.

[8]  M. Jadoul,et al.  Potassium-Binding Resins: Associations with Serum Chemistries and Interdialytic Weight Gain in Hemodialysis Patients , 2014, American Journal of Nephrology.

[9]  H. Morgenstern,et al.  Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[10]  J. Kalbfleisch,et al.  Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality , 2012, Kidney international.

[11]  R. Foley,et al.  Long interdialytic interval and mortality among patients receiving hemodialysis. , 2011, The New England journal of medicine.

[12]  M. Burnier,et al.  Haemodynamic consequences of changing potassium concentrations in haemodialysis fluids , 2011, BMC nephrology.

[13]  C. Herzog,et al.  Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. , 2011, Kidney international.

[14]  M. Valsecchi,et al.  Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  R. Passman,et al.  NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients , 2008, Seminars in dialysis.

[16]  S. Severi,et al.  Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  S. Greenland,et al.  Serum and dialysate potassium concentrations and survival in hemodialysis patients. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[18]  G. Russell,et al.  Characteristics of sudden death in hemodialysis patients. , 2006, Kidney international.

[19]  K. D. Workgroup.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  M. Kutner,et al.  The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  Nicole A. Lazar,et al.  Statistical Analysis With Missing Data , 2003, Technometrics.

[22]  G. Chertow,et al.  Cardiac arrest and sudden death in dialysis units. , 2001, Kidney international.

[23]  H. Boshuizen,et al.  Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.

[24]  A Blumberg,et al.  Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  S. Cerutti,et al.  Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias. , 1996, Kidney international.

[26]  J. Stock,et al.  Instrumental Variables Regression with Weak Instruments , 1994 .

[27]  M. Beach,et al.  Safety and efficacy of low-potassium dialysate. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  R. Elias,et al.  Dialysate and Serum Potassium in Hemodialysis. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  Ananda Sen,et al.  Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[30]  M. Tonelli,et al.  Dialysate potassium and risk of death in chronic hemodialysis patients. , 2010, Journal of nephrology.

[31]  Trevillore E. Raghunathan,et al.  IVEware: Imputation and Variance Estimation Software User Guide , 2002 .

[32]  R. Wolfe,et al.  The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study , 2000 .

[33]  M. Perazella,et al.  Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis. , 1997, Journal of general internal medicine.